CVSA
Covista Inc.
$115.82
-16.29 (-12.33%)
At close · Jul 15
Market Cap
$3.96B
Shares
34,030,887
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.79B
+12.9%
FY2025
Net Income
$237.07M
+73.3%
FY2025
Gross Margin
56.86%
+0.9pp
FY2025
Operating Margin
19.1%
+5.4pp
FY2025
Diluted EPS
$6.18
+82.3%
FY2025
Operating Cash Flow
$337.9M
+14.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.93B – $1.95B | $1.91B | $1.79B | $1.58B | $1.45B | $1.38B | $899.25M | $866.43M | $1.01B | $960.28M | $1.21B | $1.08B | $1.91B | $465.94M | $415.4M | $350.5M | $269.04M | $1.92B | $1.46B | |
| — | $8.11M | — | — | — | $3.82M | $4.09M | $3.69M | $3.97M | $598K | $4.91M | — | — | — | — | — | — | — | — | |
| — | $65.92M | — | — | — | — | — | — | -$15.81M | -$8.79M | -$4.24M | -$5.27M | -$3.25M | -$1.9M | — | — | — | — | — | |
| — | $815.84M | $771.43M | $698.55M | $648.49M | $659.78M | $457.91M | $457.17M | $471.78M | $461.56M | $638.25M | $568.95M | $1B | $983.44M | $962.22M | $960.81M | $914.39M | $826.09M | $669.67M | |
| — | $1.09B | $1.02B | $886.1M | $802.34M | $722.07M | $441.34M | $409.26M | $542.06M | $498.72M | $569.66M | $511.13M | $909.89M | -$517.49M | -$546.82M | -$610.31M | -$645.35M | $1.09B | $791.78M | |
| — | — | 56.86% | 55.92% | 55.3% | 52.25% | 49.08% | 47.24% | 53.47% | 51.94% | 47.16% | 47.32% | 47.64% | -111.06% | -131.64% | -174.12% | -239.87% | 56.87% | 54.18% | |
| — | $723.49M | $672M | $632.97M | $586.01M | $566.49M | $292.48M | $280.29M | $359.34M | $327.71M | $369.04M | $352.65M | $708.29M | $727.87M | $756.38M | $789.9M | $744.37M | $678.19M | $548.07M | |
| — | $11.22M | $11.22M | $35.64M | $61.24M | $97.27M | $0 | $0 | $6.95M | $6.5M | $11.17M | $5.19M | $4.09M | $6.42M | $9.48M | $10M | $4.73M | $11M | $10.63M | |
| — | $5.62M | $3.31M | $1.87M | $18.82M | $25.63M | $6.87M | $23.68M | $53.07M | $3.85M | $12.97M | $2.39M | $42.91M | $32.72M | $26.23M | $7.1M | $0 | — | — | |
| — | $1.54B | $1.45B | $1.37B | $1.28B | $1.31B | $788.85M | $756.36M | $858.01M | $793.12M | $1.07B | $923.99M | $1.75B | $1.74B | $1.8B | $1.83B | $1.66B | $1.5B | $1.23B | |
| — | $364.86M | $341.54M | $217.05M | $168.17M | $76.75M | $110.4M | $110.07M | $155.83M | — | — | — | $156.91M | $181.27M | $166.93M | $238.93M | $501.51M | $410.9M | $234.83M | |
| — | — | 19.1% | 13.7% | 11.59% | 5.55% | 12.28% | 12.7% | 15.37% | — | — | — | 8.22% | 38.9% | 40.18% | 68.17% | 186.4% | 21.45% | 16.07% | |
| — | $46.49M | $52.32M | $63.66M | $63.1M | $129.35M | $41.37M | $19.51M | $19.9M | $11.58M | $9.14M | $5.93M | $5.31M | $3.63M | — | — | — | — | — | |
| — | $442K | — | — | — | — | — | — | — | — | — | — | $2.06M | $1.73M | $1.65M | $817K | $1.54M | $2.08M | $5.25M | |
| — | $6.93M | $9.29M | $10.54M | $6.97M | $1.11M | $6.73M | $94.92M | -$16.08M | -$10.98M | — | — | -$3.25M | -$1.9M | -$1.96M | $1.9M | $256K | $1.72M | — | |
| — | — | — | — | — | — | — | $0 | $0 | -$138K | -$694K | $0 | $0 | — | — | — | — | — | — | |
| — | $1.37M | $1.07M | $1.37M | -$3.69M | -$3.27M | $2.64M | $18K | -$153K | $0 | — | — | — | — | — | — | — | $1.23M | $43K | |
| — | $325.3M | $298.51M | $163.94M | $112.04M | -$51.49M | $75.77M | $204.99M | $170.18M | $198.68M | $131.26M | $150.82M | $153.66M | $179.37M | $164.97M | $240.83M | $501.76M | $412.62M | $237.35M | |
| — | $75.63M | $65.84M | $26.22M | $10.28M | -$15.54M | $12.32M | -$14.94M | $32.88M | $88.11M | $9.59M | $25.33M | $18.54M | $27.7M | $39.23M | $70.9M | $166.54M | $132.64M | $71.7M | |
| — | $234.06M | $237.07M | $136.78M | $93.36M | $310.99M | $70.03M | -$85.33M | $95.17M | $33.77M | $122.28M | -$3.17M | $139.9M | $134.03M | $106.79M | $141.57M | $330.4M | $279.91M | $165.61M | |
| — | — | 13.26% | 8.63% | 6.43% | 22.51% | 7.79% | -9.85% | 9.39% | 3.52% | 10.12% | -0.29% | 7.32% | 28.77% | 25.71% | 40.39% | 122.81% | 14.62% | 11.33% | |
| — | — | — | — | — | — | -$434K | -$444K | $413K | $528K | $997K | $410K | $800K | $679K | $2.05M | $816K | $427K | $74K | $39K | |
| — | — | — | $136.78M | $93.36M | $317.98M | $71.72M | $42.9M | $100.37M | -$47.55M | $106M | $30.74M | $80.49M | $135.77M | $96.55M | $120.76M | $336.66M | $282.65M | — | |
| USD/shares | — | — | $6.39 | $3.47 | $2.08 | $6.43 | $1.36 | -$1.59 | $1.63 | $0.55 | $1.93 | -$0.05 | $2.17 | $2.09 | $1.66 | $2.11 | $4.73 | $3.92 | $2.32 |
| USD/shares | $7.95 – $8.15* | — | $6.18 | $3.39 | $2.05 | $6.43 | $1.36 | -$1.58 | $1.60 | $0.54 | $1.91 | -$0.05 | $2.14 | $2.07 | $1.65 | $2.09 | $4.68 | $3.87 | $2.28 |
| shares | — | — | 37.09M | 39.41M | 44.78M | 48.39M | 51.32M | 53.66M | 58.54M | 61.46M | 63.5M | 64.04M | 64.55M | 64.21M | 64.29K | 67.18K | 69.9K | 71.33M | — |
| shares | — | — | 38.33M | 40.31M | 45.6M | 48.39M | 51.65M | 54.09M | 59.33M | 62.28M | 64.02M | 64.37M | 65.28M | 64.85M | 64.61K | 67.71K | 70.62K | 72.27M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $1.87B in buybacks, $167.81M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.26×
Education & Training Services median 1.84×
EV/EBIT
11.81×
Education & Training Services median 13.48×
P/E (TTM)
18.13×
Education & Training Services median 20.02×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Chamberlain University Segment | $725,774,000 | $633,522,000 | $571,034,000 | $557,536,000 | $563,814,000 | $511,655,000 | — | — |
| Walden University Segment | $693,430,000 | $595,332,000 | $533,725,000 | $485,393,000 | $0 | — | — | — |
| Medical and Veterinary | $369,086,000 | $355,798,000 | $346,067,000 | $338,913,000 | $335,434,000 | $354,772,000 | — | — |
| Financial Services | — | — | — | — | $205,479,000 | — | $167,211,000 | $147,195,000 |
| Home Office and Other | — | — | — | — | — | — | -$3,229,000 | -$2,592,000 |
| Medical and Healthcare | — | — | — | — | $906,901,000 | — | $849,861,000 | $815,674,000 |
By Geography (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Domestic Operations | $1,419,204,000 | $1,228,854,000 | $1,104,759,000 | $1,042,929,000 | $563,814,000 | $511,655,000 | $606,363,000 | $578,157,000 |
| Barbados St. Kitts and St. Maarten | $369,086,000 | $355,798,000 | $346,067,000 | $338,913,000 | $335,434,000 | $354,772,000 | $362,427,000 | — |
| Barbados, Dominica, St. Kitts, and St. Maarten | — | — | — | — | — | — | $362,427,000 | $342,831,000 |
| International Operations | — | — | — | — | — | — | $407,480,000 | $382,120,000 |
| Other International Operations | — | — | — | — | — | — | $45,053,000 | $39,289,000 |
By Product & Service (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Tuition | $1,778,417,000 | $1,571,243,000 | $1,439,082,000 | $1,371,311,000 | $895,973,000 | $848,153,000 | — | — |
| Other Services | $9,873,000 | $13,409,000 | $11,744,000 | $10,531,000 | $3,275,000 | $18,274,000 | $13,953,000 | $992,000 |
| Conferences Seminars | — | — | — | — | — | — | $27,794,000 | $21,997,000 |
| Higher Education | — | — | — | — | — | — | $835,908,000 | $815,674,000 |
| Memberships Subscriptions | — | — | — | — | — | — | $20,092,000 | $13,728,000 |
| Test Preparation Certifications | — | — | — | — | — | — | $116,096,000 | $107,886,000 |
Key facts
CIK
730464
CUSIP
00737L103
13F (30d)
29 filings
28 filers
Visit website
Investor relations